Targeting apoptosis in prostate cancer

被引：35

作者：

DiPaola, RS ^{[1
]}

Patel, J ^{[1
]}

Rafi, MM ^{[1
]}

机构：

[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dean & Betty Gallo Prostate Canc Ctr, New Brunswick, NJ 08901 USA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2001年 / 15卷 / 03期

关键词：

D O I：

10.1016/S0889-8588(05)70229-X

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

This article reviews current efforts to modulate apoptotic pathways and define new targets that could be important in the treatment of prostate cancer.

引用

页码：509 / +

页数：17

共 92 条

[1] Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients [J].

Aas, T ;

Borresen, AL ;

Geisler, S ;

SmithSorensen, B ;

Johnsen, H ;

Varhaug, JE ;

Akslen, LA ;

Lonning, PE .

NATURE MEDICINE, 1996, 2 (07) :811-814

[2] NF-kappa B: Ten years after [J].

Baeuerle, PA ;

Baltimore, D .

CELL, 1996, 87 (01) :13-20

[3] AN APOPTOSIS-INHIBITING GENE FROM A NUCLEAR POLYHEDROSIS-VIRUS ENCODING A POLYPEPTIDE WITH CYS/HIS SEQUENCE MOTIF [J].

BIRNBAUM, MJ ;

CLEM, RJ ;

MILLER, LK .

JOURNAL OF VIROLOGY, 1994, 68 (04) :2521-2528

[4]

Blagosklonny MV, 1996, CANCER RES, V56, P1851

[5] PROTEINS REGULATING RAS AND ITS RELATIVES [J].

BOGUSKI, MS ;

MCCORMICK, F .

NATURE, 1993, 366 (6456) :643-654

[6]

BOOKSTEIN R, 1993, CANCER RES, V53, P3369

[7]

BOS JL, 1989, CANCER RES, V49, P4682

[8] Dominant-negative p53 mutations selected in yeast hit cancer hot spots [J].

Brachmann, RK ;

Vidal, M ;

Boeke, JD .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (09) :4091-4095

[9] INTERFERON-BETA TREATMENT OF METASTATIC PROSTATE-CANCER [J].

BULBUL, MA ;

HUBEN, RP ;

MURPHY, GP .

JOURNAL OF SURGICAL ONCOLOGY, 1986, 33 (04) :231-233

[10]

Cairns P, 1997, CANCER RES, V57, P4997

← 1 2 3 4 5 6 7 8 9 10 →